IRCT20201209049660N1已完成3 期
The effect of fenofibrate on term neonatal hyperbilirubinemia admitted to hospital
Technology and Research Vice-chancellery, Hormozgan University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 days 至 7 days（—）
- 性别
- All
入选标准
- •Gestational age >= 37 weeks
- •Weight >= 2500 g
- •Age >=72 hours and <=7 days
- •Total bilirubin >=15 mg/dl and <=20 mg/dl
排除标准
- •Hemolytic disease (ABO or Rh incompatibility)
- •Direct hyperbilirubinemia >2 mg/dl
- •G6PD deficiency
- •Any specific disease including infections, systemic diseases, cephalohematoma, bowel obstruction, asphyxia, congenital anomalies, or chromosomal abnormalities
- •History of phenobarbital intake before or after birth
研究者
相似试验
尚未招募
4 期
Fenofibrate IN JAUNDICE OF HEALTHY NEWBORCTRI/2016/07/007069Government Medical College Sir T hospital Bhavnagar60
Unknown
不适用
Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control TrialHyperbilirubinemia, NeonatalNCT04868019Shaheed Zulfiqar Ali Bhutto Medical University60
已完成
4 期
Role of Fenofibrate in Neonatal JaundiceNeonatal JaundiceNCT06451900Ain Shams University75
招募中
3 期
The effect of fenofibrate on the prevention of neonatal hyperbilirubinemia in mothers with O type blood groupIRCT20200822048473N1Babol University of Medical Sciences120
已完成
2 期
Effect of clofibrate in low birth weight neonates' hyperbilirubinemiaCondition 1: low birth weight. Condition 2: hyperbilirubinemia.Other low birth weightNeonatal jaundice associated with preterm deliveryIRCT138708291162N8mashhad university of medical science60